Mitomycins
Showing 1 - 25 of 210
Urothelial Carcinoma Ureter, Urothelial Cancer of Renal Pelvis Trial (Mitomycin C)
Not yet recruiting
- Urothelial Carcinoma Ureter
- Urothelial Cancer of Renal Pelvis
- Mitomycin C
- (no location specified)
Jul 31, 2023
Glottic Web of Larynx, Laryngeal Stenosis, Glottic Carcinoma Trial in Shanghai (Curcumin, Mitomycin-C)
Recruiting
- Glottic Web of Larynx
- +5 more
-
Shanghai, Shanghai, ChinaEye & ENT Hospital of Fudan University
Jan 15, 2023
Urothelial Cancer of Renal Pelvis, Urothelial Carcinoma of the Renal Pelvis and Ureter, Urothelial Carcinoma Ureter Trial
Available
- Urothelial Cancer of Renal Pelvis
- +5 more
- Mitomycin for pyelocalyceal solution
- (no location specified)
Aug 5, 2022
Bladder Cancer Trial in Goyang (intravesical mitomycin-C 40mg/20ml instillation)
Completed
- Bladder Cancer
- intravesical mitomycin-C 40mg/20ml instillation
-
Goyang, Korea, Republic ofNational Cancer Center
Jan 30, 2023
Urothelial Carcinoma, Urothelial Carcinoma Recurrent, Urothelial Carcinoma Ureter Trial (Jelmyto (mitomycin) for pyelocalyceal
Not yet recruiting
- Urothelial Carcinoma
- +7 more
- Jelmyto (mitomycin) for pyelocalyceal solution
- (no location specified)
May 22, 2023
Hepatocellular Carcinoma, Peritoneal Metastasis, Hyperthymic Trial in Chengdu (mitomycin C-based hyperthermic intraperitoneal
Recruiting
- Hepatocellular Carcinoma
- +3 more
- mitomycin C-based hyperthermic intraperitoneal chemotherapy
-
Chengdu, Sichuan, ChinaWest China Hospital
Sep 14, 2022
Pterygium Trial in Menoufia (Mitomycin c)
Completed
- Pterygium
- Mitomycin c
-
Menoufia, EgyptFaculty of Medicine, Menoufia University
Nov 16, 2022
Punctal Stenosis Trial in Damieta (3-snip punctoplasty, 3-snip punctoplasty and Mitomycin C)
Completed
- Punctal Stenosis
- 3-snip punctoplasty
- 3-snip punctoplasty and Mitomycin C
-
Damieta, New Damietta, EgyptEhab tharwat
Oct 15, 2022
Esophageal Stenosis, Anastomotic Stenosis Trial in Philadelphia (Mitomycin C, Control)
Withdrawn
- Esophageal Stenosis
- Anastomotic Stenosis
- Mitomycin C
- Control
-
Philadelphia, PennsylvaniaFox Chase Cancer Center
Apr 1, 2022
Locally Advanced Anal Canal Cancer Trial in France (5Fluorouracile and Mitomycin-C, Simultaneously integrated boost of intensity
Active, not recruiting
- Locally Advanced Anal Canal Cancer
- 5Fluorouracile and Mitomycin-C
- Simultaneously integrated boost of intensity modulated radiation therapy (SIB-IMRT) by tomotherapy
-
Angers, France
- +7 more
Dec 7, 2022
Presbyopia Trial in Bloomington, Dallas, San Antonio (Mitomycin c, Raindrop Near Vision Inlay)
Terminated
- Presbyopia
- Mitomycin c
- Raindrop Near Vision Inlay
-
Bloomington, Minnesota
- +2 more
Aug 15, 2022
Anal Squamous Cell Carcinoma Trial in New York (Artificial Intelligence Guided Daily Radiotherapy Treatment Planning and
Recruiting
- Anal Squamous Cell Carcinoma
- Artificial Intelligence Guided Daily Radiotherapy Treatment Planning and Delivery
- +3 more
-
New York, New YorkColumbia University Irving Medical Center
Apr 27, 2023
Gastric Adenocarcinoma, Esophagogastric Junction, Gastric Cancer Trial run by the National Cancer Institute (NCI) (Surgery,
Recruiting
- Gastric Adenocarcinoma
- +2 more
- Surgery
- +3 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Feb 2, 2023
Urothelial Carcinoma of the Bladder Trial in Washington, Baltimore, Philadelphia (drug, radiation, procedure)
Active, not recruiting
- Urothelial Carcinoma of the Bladder
- Methotrexate
- +7 more
-
Washington, District of Columbia
- +3 more
Dec 2, 2022
Bladder Cancer, Non-muscle Invasive Trial in Biel (Epirubicin, Mitomycin, Gemcitabine)
Recruiting
- Bladder Cancer
- Non-muscle Invasive
- Epirubicin
- +3 more
-
Biel, SwitzerlandRoland Seiler
Nov 17, 2022
Lung Non-Small Cell Carcinoma, Mediastinal Tumor, Pleural Tumor Trial in Duarte (Angiography, Computed Tomography, Ethiodized
Not yet recruiting
- Lung Non-Small Cell Carcinoma
- +2 more
- Angiography
- +5 more
-
Duarte, CaliforniaCity of Hope Medical Center
Jan 3, 2023
Anal Cancer Trial in Cincinnati (Radiation (reduced elective nodal dose (30.6 Gy), Capecitabine, Mitomycin c)
Not yet recruiting
- Anal Cancer
- Radiation (reduced elective nodal dose (30.6 Gy)
- +2 more
-
Cincinnati, OhioUniversity of Cincinnati Medical Center
Jun 5, 2023
Urothelial Carcinoma Trial in Gainesville (Mitomycin c)
Active, not recruiting
- Urothelial Carcinoma
- Mitomycin c
-
Gainesville, FloridaUniversity of Florida
Dec 6, 2022
Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, Peritoneal Carcinomatosis Trial in Houston (Cisplatin,
Active, not recruiting
- Gastric Adenocarcinoma
- +2 more
- Cisplatin
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Apr 12, 2022
Peritoneal Carcinomatosis Trial in Lexington (Mitomycin C, flat dose 40 mg, Mitomycin C, weight-based dose 12.5 mg/m2)
Recruiting
- Peritoneal Carcinomatosis
- Mitomycin C, flat dose 40 mg
- Mitomycin C, weight-based dose 12.5 mg/m2
-
Lexington, KentuckyUniversity of Kentucky
Mar 1, 2022
Squamous Cell Carcinoma of the Head and Neck, Squamous Cell Carcinoma, Head and Neck Trial in Saint Louis (Mitomycin-C,
Active, not recruiting
- Squamous Cell Carcinoma of the Head and Neck
- Squamous Cell Carcinoma, Head and Neck
-
Saint Louis, MissouriWashington University School of Medicine
Jun 21, 2022
Appendix Cancer, Colorectal Cancer Trial in United States (Cytoreductive Surgery, HIPEC with Mitomycin-C, EPIC with FUDR and
Recruiting
- Appendix Cancer
- Colorectal Cancer
- Cytoreductive Surgery
- +2 more
-
Miami, Florida
- +8 more
Jan 12, 2023
